Gastroenterology Research, ISSN 1918-2805 print, 1918-2813 online, Open Access |
Article copyright, the authors; Journal compilation copyright, Gastroenterol Res and Elmer Press Inc |
Journal website http://www.gastrores.org |
Original Article
Volume 10, Number 3, June 2017, pages 182-189
Histology and Glutamine Synthetase Immunoreactivity in Liver Biopsies From Patients With Congestive Heart Failure
Figures
Tables
Fibrosis stage | Definition | Score/code |
---|---|---|
No fibrosis | 0 | |
Central zone fibrosis | 1 | |
Central zone and mild portal fibrosis, with accentuation at central zone | 2A | |
Central zone and mild portal fibrosis, with accentuation at portal zone | 2B | |
Bridging fibrosis | 3 | |
Cirrhosis | 4 | |
Central zone fibrosis | ||
No fibrosis | Absent | |
Presence of fibrosis | Present | |
Sinusoidal dilatation | ||
Normal width of sinusoids | Absent | |
Widening of sinusoids | Present | |
Centrilobular hemorrhage | ||
Red blood cells confined in sinusoids | Absent | |
Red blood cells beyond sinusoids | Present | |
Hepatocyte atrophy | ||
Normally sized hepatocytes | Absent | |
Hepatocyte smaller than normal hepatocytes | Present | |
Steatosis grade | ||
No steatosis | Absent | |
(< 5% of biopsy volume) | Minimal | |
(5-33% of biopsy volume) | Mild | |
(34-66% biopsy volume) | Moderate | |
(≥ 67% of biopsy volume) | Severe | |
Cholestasis | ||
No cholestasis | Absent | |
Cholestasis in hepatocytes, canaliculi, or cholangioles | Present | |
Hepatocyte ballooning | ||
No ballooning in any hepatocytes | Absent | |
Enlarged round hepatocytes with rarefication of cytoplasm | Present | |
Mallory hyalines | ||
No | Absent | |
Any intrahepatocytic ropy eosinophilic filaments | Present | |
Ductular proliferation | ||
Normal bile duct profile | Absent | |
Duct-like structure with or without lumen at the periphery of limiting plate | Present | |
Polymorphonuclear leukocyte inflammation | ||
No neutrophilic inflammation | Absent | |
Rare neutrophils in the portal tracts and the lobules | Present | |
Mononuclear inflammation | ||
No mononuclear inflammation | Absent | |
Mononuclear inflammatory cells in the sinusoids, portal tracts, or in the lobules | Present |
N (%) | |
---|---|
Stage of fibrosis | |
No fibrosis | 5 (14) |
Centrilobular fibrosis only (1) | 4 (11) |
Centrilobular (prominent) and portal fibrosis (2A) | 6 (17) |
Centrilobular and portal (prominent) fibrosis (2B) | 5 (14) |
Bridging fibrosis (3) | 6 (17) |
Cirrhosis (4) | 4 (11) |
Not cirrhosis, but with fibrosis of indeterminate degree | 6 (17) |
Centrilobular fibrosis | |
Absent | 6 (17) |
Present | 25 (69) |
Indeterminate | 5 (14) |
Sinusoidal dilatation | |
Absent | 8 (22) |
Present | 26 (72) |
Indeterminate | 2 (6) |
Hepatocyte atrophy | |
Absent | 12 (34) |
Present | 21 (58) |
Indeterminate | 3 (8) |
Centrilobular hemorrhage | |
Absent | 15 (42) |
Present | 17 (47) |
Indeterminate | 4 (11) |
Steatosis | |
< 5% | 34 (94) |
5-33% | 1 (3) |
33-66% | 0 (0) |
> 66% | 1 (3) |
Ballooning | |
Absent | 35 (97) |
Present | 1 (3) |
Mallory hyalines | |
Absent | 36 (100) |
Present | 0 (0) |
Cholestasis | |
Absent | 35 (97) |
Present | 1(3) |
Lobular polymorphonuclear leukocyte infiltration | |
Absent | 36 (100) |
Present | 0 (0) |
Lobular mononuclear inflammation | |
Absent | 21 (58) |
Present | 13 (36) |
Indeterminate | 2 (6) |
Portal polymorphonuclear leukocyte infiltration | |
Absent | 35 (97) |
Present | 1 (3) |
Portal mononuclear inflammation | |
Absent | 10 (28) |
Present | 19 (53) |
Indeterminate | 7 (19) |
Ductular proliferation | |
Absent | 7 (20) |
Present | 13 (36) |
Indeterminate | 16 (44) |
Histologic feature | K value (95% CI) | Strength of agreement |
---|---|---|
Sinusoidal dilation (absent/present) | 0.66 (0.41 - 0.86) | Substantial |
Centrilobular atrophy (absent/present) | 0.51 (0.35 - 0.70) | Moderate |
Centrilobular hemorrhage (absent/present) | 0.35 (0.19 - 0.53) | Fair |
Centrilobular fibrosis (absent/present) | 0.43 (0.21 - 0.68) | Moderate |
Fibrosis stage (congestive hepatic fibrosis score) | 0.35 (0.24 - 0.49) | Fair |
Simplified fibrosis stage (CHFS 0-2B/3-4) | 0.45 (0.31 - 0.61) | Moderate |
Histologic feature | Correlation coefficient | Significance (P value) |
---|---|---|
Sinusoidal dilation (absent/present) | 0.209 | 0.317 |
Centrilobular atrophy (absent/present) | 0.092 | 0.66 |
Centrilobular hemorrhage (absent/present) | 0.192 | 0.356 |
Centrilobular fibrosis (absent/present) | -0.126 | 0.546 |
Fibrosis stage (congestive hepatic fibrosis score) | 0.107 | 0.571 |